Brind.

Sanofi and Regeneron Pharmaceuticals announce a joint initiative to develop Praluent cholesterol medication and initiatives like TrumpRx.gov.

1 report, 1 independent Updated Jul 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Sanofi Regeneron Pharmaceuticals Donald Trump

How it developed

Newest first. Tap a step to see who reported it.

Sep 12Sanofi completed the repayment of a development balance.Sub-event
Jul 24Jointly developed Praluent cholesterol medication and initiatives like TrumpRx.gov announced via the administration.1 source
- foxbusiness.com

Keep exploring

The entities involved

Sanofi
French pharmaceutical company
- Sanofi and the Association of Science and Technology Centers announced a partnership focused on environmental education.Fri 23:12
- Industry experts met in San Diego, involving representatives from Sanofi, Cardinal Health, and Marsh.Fri 18:25
Regeneron Pharmaceuticals
American pharmaceutical company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Trump ended the ceasefire agreement with Iran following recent attacks by Iranian forces.Mon 18:02
- The Trump administration utilized the Department of Health & Human Services for an AI tool.Mon 18:02

Coverage

Newest first; wire copies grouped

Jul 24foxbusiness.comAmericans save more than $700M on prescription medications through TrumpRx, White House says